2024-03-21 LabMCoP Meeting Notes
Date
Mar 21, 2024
Attendees
Present | Name | Organization |
---|---|---|
X | Nancy Cornish | CDC |
X | Manjula Gama-Ralalage | CDC |
X | Riki Merrick | APHL |
X | Christina Gallegos | APHL |
X | Amy Liu | Inductive Health / APHL |
X | Raj Dash | Duke / CAP |
X | John Snyder | National Library of Medicine (SNOMED CT) |
| Andrea Pitkus | UW |
X | Kathy Walsh | Labcorp |
| Rob Hausam | Hausam Consulting |
| Doug York | APHL |
| Pam Banning | 3M |
Discussion topics
Topic | Discussed? | Notes |
---|---|---|
Upcoming OOO | Yes |
|
Previous Action Items | Yes |
|
CDC and ONC meeting Update |
| Carmela is detailed from ONC to the new CDC Standards Devision supporting CDC comments on USCDI V5 draft specifically talking about specimen collection date/time, performed test date/time, lab received date/time and specimen collection method Lab related date/timestamps - vs specific triggers for collecting those, that are clincially important - specimen collection date/time is different from generic procedure time (since specimen collection, while techincally a procedure, is not specifically captured as such in HIT systems) specialization of generic elements - example medical record number vs patient identifier (in 2019 congress was having a discussion around a national unique patient identifier) test kit unique identifier (model = device level), lot number (may be harder than the device level id) and instance level identifier (serial number) = production identifier - these things are recorded in the lab, but not currently in the LIS = UDI Basics currently all FDA 510k devices have to have a device level identifier UDI - it would be great if you could just scan the test kit / reagent / instrument barcode when the lab gets the testkit/reagent/instrument |
Specimen CMT - review of terms with questions |
|
|
CALL ADJOURNED |
| 12:57 PM ET |
Specimen CMT pilot implementers | No |
|
Specimen CMT - Hosting Options | No |
|
Specimen CMT - education | No |
|
Specimen CMT - tracking implementation impact
| No |
|
Specimen CMT - Compare to NHS Medical Terminology testing | No |
|
LOINC to SNOMED CT mapping | No |
|
Reporting Biomarkers to Cancer registries | No | National Program of Cancer Registries (NPCR) | CDC Sandy will put together a one-pager |
Future projects for this call after CMT | No |
|
From Chat:
You 12:00 PM
2024-03-21 LabMCoP Meeting Notes
Rajesh Dash to Everyone 12:15 PM
Production Identifier
UDI Basics
vgh5@cdc.gov 12:25 PM
I will be out of office April 25
John Snyder (NLM) 12:33 PM
Groshong catheters are a type of central venous catheter, which are placed under direct fluoroscopic visualization in an angiography suite.
Recording:
Action items
Quick decisions not requiring context or tracking
For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.
Decisions requiring context or tracking
For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.